A comparison of SARS-CoV-2 symptom prevalence, duration, and risk of hospitalisation among vaccinated individuals from the ZOE COVID Study during Omicron versus Delta variant dominant periods

Research output: Contribution to journalArticlepeer-review

478 Downloads (Pure)
Original languageEnglish
JournalThe Lancet
Publication statusAccepted/In press - 16 Feb 2022

Cite this